scholarly journals Regulated expression system for GD3 synthase cDNA and induction of differentiation in Neuro2a cells

Glycobiology ◽  
1997 ◽  
Vol 7 (8) ◽  
pp. 1067-1076 ◽  
Author(s):  
Hong Liu ◽  
Naoya Kojima ◽  
Nobuyuki Kurosawa ◽  
Shuichi Tsuji
2018 ◽  
Vol 84 (7) ◽  
Author(s):  
Michael Clayton Speed ◽  
Brett W. Burkhart ◽  
Jonathan W. Picking ◽  
Thomas J. Santangelo

ABSTRACT Robust genetic systems for the hyperthermophilic Thermococcales have facilitated the overexpression of native genes, enabled the addition of sequences encoding secretion signals, epitope, and affinity tags to coding regions, and aided the introduction of sequences encoding new proteins in these fast-growing fermentative heterotrophs. However, tightly controlled and easily manipulated systems facilitating regulated gene expression are limited for these hosts. Here, we describe an alternative method for regulatory control reliant on a cis -encoded functional riboswitch in the model archaeon Thermococcus kodakarensis . Despite the hyperthermophilic growth temperatures, the proposed structure of the riboswitch conforms to a fluoride-responsive riboswitch encoded in many bacteria and similarly functions to regulate a component-conserved fluoride export pathway. Deleting components of the fluoride export pathway generates T. kodakarensis strains with increased fluoride sensitivity. The mechanism underlying regulated expression suggested that the riboswitch-encoding sequences could be utilized as a tunable expression cassette. When appended to a reporter gene, the riboswitch-mediated control system provides fluoride-dependent tunable regulatory potential, offering an alternative system for regulating gene expression. Riboswitch-regulated expression is thus ubiquitous in extant life and can be exploited to generate regulated expression systems for hyperthermophiles. IMPORTANCE Gene expression is controlled by a myriad of interconnected mechanisms that interpret metabolic states and environmental cues to balance cell physiology. Transcription regulation in Archaea is known to employ both typical repressors-operators and transcription activators to regulate transcription initiation in addition to the regulation afforded by chromatin structure. It was perhaps surprising that the presumed ancient mechanism of riboswitch-mediated regulation is found in Bacteria and Eukarya , but seemingly absent in Archaea . We demonstrate here that a fluoride-responsive riboswitch functions to regulate a detoxification pathway in the hyperthermophilic archaeon Thermococcus kodakarensis . The results obtained define a universal role for riboswitch-mediated regulation, adumbrate the presence of several riboswitch-regulated genes in Thermococcus kodakarensis , demonstrate the utility of RNA-based regulation at high temperatures, and provide a novel riboswitch-regulated expression system to employ in hyperthermophiles.


2000 ◽  
Vol 74 (22) ◽  
pp. 10631-10638 ◽  
Author(s):  
Wataru Satoh ◽  
Yukihiko Hirai ◽  
Kenji Tamayose ◽  
Takashi Shimada

ABSTRACT Recombinant adeno-associated virus (AAV) type 2 has attracted attention because it appears to have the potential to serve as a vector for human gene therapy. An interesting feature of wild-type AAV is its site-specific integration into AAVS1, a defined locus on chromosome 19. This reaction requires the presence of two viral elements: inverted terminal repeats and Rep78/68. Accordingly, current AAV vectors lacking the rep gene lack the capacity for site-specific integration. In this report, we describe the use of Cre-loxP recombination in a novel system for the regulated, transient expression of Rep78, which is potentially cytotoxic when synthesized constitutively. We constructed a plasmid in which the p5 promoter was situated downstream of the rep coding sequence; in this configuration, rep expression is silent. However, Cre circularizes the rep expression unit, directly joining the p5 promoter to the 5′ end of the rep78 coding sequence, resulting in expression of Rep78. Such structural and functional changes were confirmed by detailed molecular analysis. A key feature of this system is that Rep expression was terminated when the circular molecule was linearized and integrated into the chromosome. Using this regulated expression system, we attempted site-specific integration of AAV vector plasmids. A PCR-based assay and analysis of fluorescence in situ hybridization showed that the AAV vector sequence was integrated into chromosome 19. Sequence analysis also confirmed that transient expression of Rep78 was sufficient for site-specific integration at the AAVS1 locus, as is observed with integration of wild-type AAV.


2016 ◽  
Vol 38 (8) ◽  
pp. 1381-1387
Author(s):  
Yasuhiro Fujino ◽  
Ryo Tanoue ◽  
Takushi Yokoyama ◽  
Katsumi Doi

2008 ◽  
Vol 72 (5) ◽  
pp. 1781-1790 ◽  
Author(s):  
Hong Liu ◽  
Takatoshi Nakagawa ◽  
Tae Kanematsu ◽  
Takafumi Uchida ◽  
Shuichi Tsuji

Gene ◽  
1996 ◽  
Vol 168 (1) ◽  
pp. 37-41 ◽  
Author(s):  
Hiroaki Sagawa ◽  
Atsushi Ohshima ◽  
Ikunoshin Kato

Angiogenesis ◽  
2004 ◽  
Vol 7 (2) ◽  
pp. 105-113 ◽  
Author(s):  
Sylvain Miraux ◽  
Sylvie Lemi�re ◽  
Raphael Pineau ◽  
Mauro Pluderi ◽  
Paul Canioni ◽  
...  

Blood ◽  
2005 ◽  
Vol 105 (4) ◽  
pp. 1424-1430 ◽  
Author(s):  
Victor M. Rivera ◽  
Guang-ping Gao ◽  
Rebecca L. Grant ◽  
Michael A. Schnell ◽  
Philip W. Zoltick ◽  
...  

AbstractGene therapy is a potential route for the delivery of secreted therapeutic proteins, but pharmacologic control of expression will generally be required for optimal safety and efficacy. Previous attempts to achieve regulated expression in largeanimal models have been thwarted by transient expression or immune responses to regulatory proteins. We evaluated the ability of the dimerizer-regulated gene expression system to achieve controlled, long-term production of erythropoietin (Epo) following intramuscular administration of adeno-associated virus (AAV) vectors to 16 primates. All animals showed dose-responsive and completely reversible elevation of Epo and hematocrit in response to the dimerizer rapamycin, or analogs with reduced immunosuppressive activity, administered intravenously or orally. Animals that received optimized dual vectors showed persistent regulated expression for the duration of the study, with no apparent immune response to Epo or the regulatory proteins. Similar results were obtained with single vectors incorporating both the Epo and regulatory genes, including those packaged into serotype 1 AAV vectors to allow use of lower viral doses. For the longest-studied animal, regulated expression has persisted for more than 6 years and 26 induction cycles. These data indicate that one-time or infrequent gene transfer followed by dimerizer regulation is a promising approach for delivery of therapeutic proteins.


2019 ◽  
Vol 13 ◽  
pp. 512-525 ◽  
Author(s):  
Jolanda M. Liefhebber ◽  
Raygene Martier ◽  
Tom Van der Zon ◽  
Sonay Keskin ◽  
Angelina Huseinovic ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document